Company Overview
Company Name
Actym Therapeutics
Address
United States
Website
actymthera.comApprox. Annual Revenue
$7.2M
Employees
40
Established
2017
About Actym Therapeutics
Actym Therapeutics is a biopharmaceutical company based in the United States. The company is developing a bacterial delivery platform, STACT, to treat cancer with powerful immunotherapies. Actym is currently evaluating its lead candidate, ACTM-838, in a phase 1 clinical trial for advanced solid tumors.
Recent changes
What changed on the Actym Therapeutics website and Google listing, as detected by Coldlytics on each visit.
Estimated revenue band moved from $2.5M-5M to $5M-10M
Estimated headcount moved from 11-20 to 21-50 employees
Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.
Find companies by what just changed →More Companies in California
Browse all companies in California →
Frequently Asked Questions about Actym Therapeutics
Categories
Technologies Used
Key Decision Makers
Andra Schemera Director Clinical Operations